TPUC3
Report
- Report Number
- 1823260-2024-01289
- Event Type
- Malfunction
- Date Received
- April 26, 2024
- Date of Event
- March 25, 2024
- Report Date
- June 25, 2024
- Manufacturer
- ROCHE DIAGNOSTICS
- Product Code
- JGQ
- UDI-DI
- 04015630919536
- PMA / PMN Number
- K141925
- Product Problem
- Yes
- Report Source
- Manufacturer report
- Reporter Location
- JA
- Reporter Occupation
- OTHER HEALTH CARE PROFESSIONAL
- Health Professional
- Yes
Narratives
THE SERIAL NUMBER OF THE COBAS 6000 C501 MODULE WAS NOT PROVIDED. THE INVESTIGATION IS ONGOING.
BASED ON THE INFORMATION PROVIDED, THE INVESTIGATION DID NOT IDENTIFY A PRODUCT PROBLEM. THE CAUSE OF THE EVENT COULD NOT BE DETERMINED.
THE INITIAL REPORTER RECEIVED QUESTIONABLE HIGH TPUC3 TOTAL PROTEIN URINE/CSF GEN.3 RESULTS FROM ONE URINE PATIENT SAMPLE TESTED ON THE COBAS 6000 C501 MODULE. THE INITIAL TPUC3 RESULT OF THE UNDILUTED PATIENT SAMPLE FROM THE MODULE WAS 152.6 MG/DL. THE REPEAT RESULT WITH THE PATIENT SAMPLE AT 1:3 DILUTION FROM THE MODULE WAS 1193.4 MG/DL. THE REPEAT RESULT OF THE UNDILUTED PATIENT SAMPLE FROM THE MODULE WAS 132.6 MG/DL. THE REPEAT RESULT USING AN IMMUNOTURBIDIMETRY LABORATORY METHOD WAS 15.6 MG/L. THE REPORTER SENT THE PATIENT SAMPLE TO AN OUTSOURCED LABORATORY. THE REPEAT RESULT FROM A COMPETITOR ANALYZER USING AN IMMUNOTURBIDITY LABORATORY METHOD WAS 5.5 MG/L. THE PATIENT SAMPLE WAS ALSO SENT TO THE INVESTIGATION LABORATORY. THE REPEAT RESULT USING A BENZONTIUM CHLORIDE METHOD WAS 155.2 MG/DL. THE INVESTIGATION LABORATORY SUSPECTS THE PRESENCE OF AN INTERFERENT IN THE PATIENT SAMPLE. ADDITIONAL TPUC3 RESULTS OF 22.4 MG/DL AND 397.8 MG/DL WERE PROVIDED. IT IS NOT CLEAR HOW THESE RESULTS RELATE TO THE EVENT. CLARIFICATION HAS BEEN REQUESTED RELATED TO THESE RESULTS BUT HAS NOT BEEN PROVIDED.
Devices
| Seq | Brand | Generic | Product Code | Manufacturer | Model | Lot | UDI-DI |
|---|---|---|---|---|---|---|---|
| 2122375 | TPUC3 | TURBIDIMETRIC, TOTAL PROTEIN | JGQ | ROCHE DIAGNOSTICS | 75158401 | 04015630919536 |
Patients
| Seq | Age | Sex | Outcome | Treatment |
|---|---|---|---|---|
| 1 | 4 YR | Male |